Literature DB >> 17567870

Chemoprophylaxis of colorectal cancer in inflammatory bowel disease: current concepts.

Jonathan S Levine1, Robert Burakoff.   

Abstract

Ulcerative colitis and Crohn's disease both confer an increased risk of developing colorectal cancer. The use of 5-aminosalicylate as a remission-inducing agent has been long accepted. Its use as a potential chemoprophylactic agent has been proposed and is used by some practitioners. This review examines the most recent data on 5-aminosalicylate as a chemoprophylactic drug as well as ursodeoxycholic acid, folic acid, azathioprine, and 6-mercaptopurine.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17567870     DOI： 10.1002/ibd.20186

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


  8 in total

1.  Pros and cons of medical management of ulcerative colitis.

Authors:  Udayakumar Navaneethan; Bo Shen
Journal:  Clin Colon Rectal Surg       Date:  2010-12

2.  Oral administration of the anti-proliferative substance taurolidine has no impact on dextran sulfate sodium induced colitis-associated carcinogenesis in mice.

Authors:  Ansgar Michael Chromik; Sebastian Huss; Hayssam Osseili; Adrien Daigeler; Sabine Kersting; Dominique Sülberg; Ulrich Mittelkötter; Thomas Herdegen; Waldemar Uhl; Annette M Müller
Journal:  J Carcinog       Date:  2010-04-16

Review 3.  Diagnosis and management of dysplasia in patients with ulcerative colitis and Crohn's disease of the colon.

Authors:  Thomas Ullman; Robert Odze; Francis A Farraye
Journal:  Inflamm Bowel Dis       Date:  2009-04       Impact factor: 5.325

4.  Thiopurines related malignancies in inflammatory bowel disease: local experience in Granada, Spain.

Authors:  María Gómez-García; Maria José Cabello-Tapia; Antonio Damián Sánchez-Capilla; Javier De Teresa-Galván; Eduardo Redondo-Cerezo
Journal:  World J Gastroenterol       Date:  2013-08-14       Impact factor: 5.742

5.  Indian Society of Gastroenterology consensus on ulcerative colitis.

Authors:  Balakrishnan S Ramakrishna; Govind K Makharia; Philip Abraham; Uday C Ghoshal; Venkataraman Jayanthi; Brij Kishore Agarwal; Vineet Ahuja; Deepak K Bhasin; Shobna J Bhatia; Gourdas Choudhuri; Sunil Dadhich; Devendra C Desai; Gopal Krishna Dhali; Bhaba Dev Goswami; Sanjeev K Issar; Ajay K Jain; Rakesh Kochhar; Ajay Kumar; Goundappa Loganathan; Sri Prakash Misra; C Ganesh Pai; Sujoy Pal; Anna Pulimood; Amarender S Puri; Ganesh N Ramesh; Gautam Ray; Shivaram P Singh; Ajit Sood; Manu Tandan
Journal:  Indian J Gastroenterol       Date:  2012-10-25

6.  Use of thiopurines and risk of colorectal neoplasia in patients with inflammatory bowel diseases: a meta-analysis.

Authors:  Jianfeng Gong; Lijing Zhu; Zhen Guo; Yi Li; Weiming Zhu; Ning Li; Jieshou Li
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

7.  Blood Cell DNA Methylation of Aging-Related Ubiquitination Gene DZIP3 Can Predict the Onset of Early Stage Colorectal Cancer.

Authors:  Yuan Quan; Fengji Liang; Deqing Wu; Xueqing Yao; Zhihuang Hu; Yuexing Zhu; Ying Chen; Andong Wu; Danian Tang; Bingyang Huang; Ruifeng Xu; Zejian Lyu; Qian Yan; Lang Luo; Zhengzhi Ning; Yong Li; Jianghui Xiong
Journal:  Front Oncol       Date:  2020-11-27       Impact factor: 6.244

8.  Preclinical cancer chemoprevention studies using animal model of inflammation-associated colorectal carcinogenesis.

Authors:  Takuji Tanaka
Journal:  Cancers (Basel)       Date:  2012-07-16       Impact factor: 6.639
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.